NexPoint Launches Life Sciences III DST Offering for CDMO Manufacturing Property in Minnesota

DALLAS, Jan. 16, 2024 /PRNewswire/ — NexPoint, a multibillion-dollar alternative investment firm1, announced the launch of NexPoint Life Sciences III DST, a Delaware Statutory Trust (the “DST”), which acquired a life sciences industrial manufacturing property in Woodbury, Minnesota (the “Property”)2. The DST seeks to raise approximately $31 million through the offering. The investment reinforces NexPoint’s commitment to life sciences real estate, which continues […]

200-acre life sciences hub set for Legacy Business Park

Community Impact recently highlighted plans for the Texas Research Quarter, NexPoint’s proposed life sciences development in Plano, Texas, and its potential to be a catalyst for research and innovation in North Texas. “Life sciences hubs, such as the Texas Research Quarter, will include the capacity to research and manufacture therapies within the same campus. This […]

NexPoint is Named a 2023 Best Places to Work in Money Management by Pensions & Investments

DALLAS – December 12, 2023 – NexPoint, a multibillion-dollar alternative investment firm, was recognized today in Pensions & Investments’ 2023 Best Places to Work in Money Management Awards. The firm was named as a top workplace in the 100-499 Employees category. Presented by Pensions & Investments, the global news source of money management, the 12th […]

NexPoint Real Estate Finance, Inc. Launches $400 Million Continuous Offering of 9.0% Series B Cumulative Redeemable Preferred Stock

DALLAS, Nov. 2, 2023 /PRNewswire/ — NexPoint Real Estate Finance, Inc. (NYSE: NREF) (“NREF” or the “Company”) announced today the launch of a continuous public offering of up to 16,000,000 shares of its new designated 9.0% Series B Cumulative Redeemable Preferred Stock (the “Series B Preferred Stock”) at a price to the public of $25.00 per share, for gross proceeds […]

NexPoint Launches NexPoint Semiconductor Manufacturing DST Offering

DALLAS, October 19, 2023 /PRNewswire/ — NexPoint, an alternative investment firm with $16.6 billion in assets under management, today announced the launch (the “Offering”) of NexPoint Semiconductor Manufacturing DST (the “Trust”), a Delaware Statutory Trust (“DST”) that owns a semiconductor manufacturing property in Temecula, California (the “Property”). The current tenant of the Property, Skorpios Technologies Inc. (the “Tenant”), is engaged in both […]

NexPoint Merger Arbitrage Fund Earns Spot on HFM U.S. Performance Awards Shortlist in Two Categories

DALLAS, Sept. 18, 2023 /PRNewswire/ — NexPoint, a multibillion-dollar alternative investment firm, announced today that the NexPoint Merger Arbitrage Fund (the “Fund”) was recognized on the shortlist for the HFM U.S. Performance Awards 2023 for the fourth consecutive year. The Fund was shortlisted in two categories: Event-Driven Over $1bn, where the Fund was one of four funds shortlisted. Best […]

NexPoint Announces Co-investment in NexPoint Life Sciences II DST, Continuing Commitment to Life Sciences with a Focus on CDMOs and cGMP Facilities

DALLAS, Sept. 12, 2023 /PRNewswire/ — NexPoint, a multibillion-dollar alternative investment platform, announces it has made an initial investment in NexPoint Life Sciences II DST, a Delaware statutory trust (DST), through a fund advised by its affiliate. The investment represents 6% of the total equity available. NexPoint plans to increase the investment size, ultimately targeting 10%-12% of the total equity […]

NexPoint’s Life Sciences Project in Plano, Texas Renamed Texas Research Quarter

DALLAS, May 18, 2023 /PRNewswire/ — NexPoint, a multibillion-dollar alternative investment firm, today announced that its cutting-edge life sciences real estate project known as the “TxS District,” a proposed 200-acre development in Plano, Texas, has been renamed the “Texas Research Quarter.” Originally signifying “Technology x Science,” the new Texas Research Quarter (“TRQ”) name was chosen to better reflect […]

NexPoint Expands Life Sciences Real Estate Footprint with Acquisition of Two Properties from Adare Pharma Solutions

Properties were indirectly acquired by NexPoint Life Sciences II DST, a Delaware statutory trust seeking to raise $42 million in equity from accredited investors via a private placement offering DALLAS, May 17, 2023 /PRNewswire/ — NexPoint, a multibillion-dollar alternative investment platform, today announced the acquisition of two life sciences industrial properties located in Philadelphia, Pennsylvania, from Frontida Biopharm, LLC, a company in the […]

Contact Us